NCT07823426 Cervical Spinal Cord Signal Abnormalities in Patients With Cervical Radicular Pain
| NCT ID | NCT07823426 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara City Hospital Bilkent |
| Condition | Cervical Radiculopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2026-10-01 |
| Primary Completion | 2027-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2026-10-01 with a primary completion date of 2027-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective observational study aims to determine the prevalence of cervical spinal cord signal abnormalities, including myelomalacia, among adult patients presenting to a tertiary pain clinic with cervical radicular pain. A total of 400 consecutive patients will be enrolled. Clinical and neurological examination findings, including the Hoffmann sign and other findings suggestive of cervical spinal cord involvement, will be recorded together with cervical magnetic resonance imaging (MRI) findings obtained as part of routine clinical care. The primary outcome is the prevalence of cervical spinal cord signal abnormalities, including myelomalacia, on cervical MRI. Secondary outcomes include the treatment strategy selected during routine clinical care, clinical and radiological factors associated with treatment selection, the relationship between the Hoffmann sign and cervical spinal cord abnormalities, and referral for surgical evaluation. This is an observational study. Participation in the study will not determine or alter diagnostic or treatment decisions, which will be made by the treating physician according to routine clinical practice.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older * Presentation to the pain clinic with cervical radicular pain * Clinical symptoms and/or examination findings consistent with cervical nerve root involvement * Availability of a cervical magnetic resonance imaging (MRI) examination suitable for evaluation * Completion of standardized neurological examination at the initial visit * Ability and willingness to provide written informed consent Exclusion Criteria: * Previous cervical spine surgery * Acute cervical spine trauma * Known cervical spinal malignancy * Active spinal infection * Known inflammatory, demyelinating, or other non-degenerative spinal cord disease * Severe cognitive impairment or communication difficulty preventing reliable clinical assessment * Inadequate or non-diagnostic cervical MRI quality * Refusal to participate
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07823426 clinical trial?
This trial is open to participants of all sexes, studying Cervical Radiculopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07823426 currently recruiting?
Yes, NCT07823426 is actively recruiting participants. Contact the research team at sabuncuulku@gmail.com for enrollment information.
Where is the NCT07823426 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07823426 clinical trial?
NCT07823426 is sponsored by Ankara City Hospital Bilkent. The trial plans to enroll 400 participants.